ABSTRACT. Infants with extrahepatic biliary atresia (EHBA) commonly develop rickets in infancy, whereas long-term survivors with EHBA commonly develop osteopenia with increasing age. We evaluated baseline vitamin D (Dz and D3), 25-OH vitamin D2 and D,, 1,25(0H)2 vitamin D, bone mineral content, and vitamin D2 and 25-OH vitamin D3 absorption in six infants and children (age 4-22 mo) with EHBA whose portoenterostomy failed to produce bile flow (group 1) and five infants and children (age 10112 to 8-4/12 y) with EHBA whose portoenterostomy repair led to good postoperative bile flow (group 2). Baseline serum vitamin Dz and DJ were undetectable in all subjects in group 1 despite supplements of 2500-5000 IU/ day, whereas all group 2 subjects given supplements (doses 400-5000 IU/d) had measurable levels. Baseline serum 25-OH vitamin D was less than 15 ng/mL in five of six (three with rickets) in group 1, whereas only one in group 2 had concentrations less than 15 ng/mL. A significantly blunted rise of vitamin D2 above baseline and reduced area under the absorption curve after 1000 IU/kg vitamin DZ were found in group 1 patients compared to group 2 (both p < 0.01), and five pediatric controls (both p < 0.01). The peak change and area under the absorption curve for serum 25-OH vitamin D3 from baseline after 10 pg/kg 25-OH vitamin D3 were significantly reduced for group 1 (both at least p < 0.05) and group 2 compared to controls (both p < 0.05). Malabsorption of supplemental doses of vitamin D compromises their efficacy to prevent rickets in infants with EHBA with poor bile flow after portoenterostomy. Despite severe malabsorption of vitamin D, we suggest that oral 25-OH vitamin D may be absorbed sufficiently to prevent rickets. (Pediatr Res 27:26-31, 1990) Abbreviations EHBA, extrahepatic biliary atresia PTH, parathyroid hormone EHBA accounts for approximately 25% of cases of neonatal cholestasis (1). Operable forms with atresia limited to the distal portions of the biliary tract account for 10-15% of the cases. In
recent years, surgical intervention for cases with no proximal duct remnant have prompted the construction of a Roux-en-Y of small intestine to the dissected liver hilum and resulted in postoperative bile flow, improvement in jaundice and survival for years in 40% of patients. Unfortunately, the remaining larger portion of subjects do not have "successful" operations and continue to have jaundice and poor bile flow postoperatively.
Infants with EHBA with poor biliary drainage after portoenterostomy have significant malabsorption of fat and fat-soluble vitamins because of intraluminal bile acid deficiency (4, 5) . Apparently as a consequence, rickets occur in 59% of affected infants with unoperated EHBA (6) . Results of previous studies in older children and adolescents with intrahepatic cholestasis have indicated that vitamin D is severely malabsorbed, whereas the absorption of 25-OH vitamin D is less impaired (7) . Our study was designed to evaluate vitamin D and 25-OH vitamin D absorption in infants and children with EHBA and to test the hypothesis that, as found in older patients, 25-OH vitamin D might be better absorbed than vitamin D in patients with EHBA, and therefore its use as a supplement would be superior to vitamin D for prevention of rickets.
MATERIALS AND METHODS

Patients and Controls. Group 1 (n = 6). Infants and children
with EHBA (age 4/ 12 to 1 -101 12 y) whose surgical exploration and formation of a portoenterostomy resulted in minimal postoperative bile flow (less than 10 mL/d), no reduction in serum bilirubin and an unfavorable clinical course characterized by poor growth, development of ascites, variceal bleeding in the first 2 y of life. Orthotopic liver transplantation was performed in three subjects. Death occurred in two subjects after these studies were completed.
Group 2 (n = 5). Infants and children with EHBA (age 1 to 8-4/12 y) with good postoperative bile flow, reduction in serum bilirubin and a favorable clinical course characterized by only moderately impaired growth and no other significant hepaticrelated complications during the first 2 y of life. Group 3 (n = 6). Control subjects (age 101 12 to 19-112 y) with noncholestatic liver disease ( n = 4) and idiopathic short stature ( n = 2).
Baseline Evaluation. Serial blood samples were  obtained for measurement of 25-OH vitamin D at time 0, +2,  +4, +8 , and +24 h as described by Stamp (8) .
Vitamin D2 Absorption. On a separate day, after a 4-h fast, a dose of 1000 IU/kg vitamin D2 (Drisdol, Winthrop Breon, New York, NY) was given by mouth. After 2 h, the subjects were allowed to eat an age-appropriate breakfast. Blood was obtained for vitamin D2 and D3 at time 0, +4, +8, +12, +24, and +48 hours, as outlined by Lo et al. (9) .
This project was approved by the Institutional Review Board involving Human Subjects of the Cincinnati Children's Hospital Medical Center and the Scientific Advisory Committee of the General Clinical Research Center. Written informed consent was obtained from parents or guardians.
Analytical Methods. Baseline liver function tests, Ca, P, Mg, and prothrombin times were measured by standard techniques in the clinical laboratories of the Children's Hospital Medical Center. PTH was measured using a RIA technique which measures amino acid 44-68 (Immunonuclear Corp., Stillwater, MN) with inter-and intraassay coefficients of variation of 14.0 and 6.6%, respectively. Serum 25-OH vitamin D analyzed for the 25-OH vitamin D tolerance tests was measured by a modification of Haddad and Chyu (10) using salicylic acid chromatography and rat serum binder with intraassay coeficients of variation for standards of 6.8% and for serum controls of 15%.
Determination of serum vitamin D2, D3, 25-OH vitamin D2, 25-OH vitamin D3, and 1,25(OH)2 vitamin D was accomplished using previously published techniques using solid-phase extraction of vitamin D and its metabolites from serum (1 1-13). Vitamins D2, D3, 25-OH vitamin D2, and 25-OH vitamin D3 were then quantitated by direct UV absorption after separation by high-performance liquid chromatography (1 3). 1 ,25(OH)2 vitamin D levels were quantitated by a radioreceptor assay using the calf thymus receptor for 1,25(OH)2 vitamin D (11, 12) . Normal levels for pregnant white females receiving 400 IU vitamin DJday for vitamin D2 are 0-0.75 ng/mL and for vitamin D3 are 0-1.70 ng/mL (14) . Normal values of total 25-OH vitamin D for adults using this technique are 15 to 50 ng/ mL, whereas normal 1,25(OH)2 vitamin D concentrations are 30 to 50 pg/mL. Inter-and intraassay coefficients of variation are < 10% for all of these determinations. Bone mineral content was measured using direct single beam photon absorptiometry of the distal one-third site of the radius using a Lunar Bone Mineral analyzer that is specifically designed for use in infants and children. A narrow band of low-energy radiation (1251) and a collimated scintillation detector were moved across the forearm. Bone mineral analysis by this method has been shown to indicate accurately (1 to 3% error) the ash weight of bone (15) . Our interassay coefficient of variation is less than 6.5%. All measurements were made on the left arm and the average of these measurements was used. Age-and sex-specific norms were used for comparisons because comparisons to single age-matched controls may not accurately reflect population normals (16, 17) .
Statistical Analysis. All results are reported as the mean &SE. Statistical analyses included two-tailed Student's t test and linear regression. Partial areas under the curve were calculated using the linear/logarithmic trapezoidal rule and were computed using PKCALC ( 18) .
RESULTS
Clinical characteristics of both groups with extrahepatic biliary atresia are summarized in Table 1 . All subjects in group 1 had serum total bilirubin concentrations greater than 8.8 mg/dL. Only one subject in group 2 (no. 1) had a markedly elevated total serum bilirubin (7.3 mg/dL). This patient remained jaundiced at age 43 mo but had no additional significant liver diseaserelated complications and was growing moderately well. Only one subject in group 1 (no. 3) had prolongation of prothrombin time of more than 3 s above control indicating hepatic synthetic function was maintained in most subjects. All but one subject were receiving supplemental vitamin D (400-5000 IU). One subject (group 2, no. 5) was receiving no vitamin D supplement (see Table 2 ).
Serum calcium and phosphorus were both reduced in two subjects in group 1, whereas one subject had reduced serum calcium. All subjects with decreased serum calcium also have hypoalbuminemia. Serum magnesium was normal in all subjects. All subjects and controls had normal PTH concentrations. No subjects in group 1 had measurable vitamin D concentrations despite 2500-5000 IU/day supplement. In contrast, all subjects in group 2 who were receiving vitamin D supplements had measurable serum vitamin D concentrations. In the one subject
* Laboratory reference: 140-325 U/L, 0-2 y; 237-739 U/L, 2-17 y. receiving no supplement, serum vitamin D concentrations were not measurable. In group 1, total serum 25-OH vitamin D was less than 15 ng/ mL in five of six subjects. In each case, the 25-OH vitamin D2 concentration (including the subject receiving supplemental vitamin D3) exceeded the 25-OH vitamin D, concentration. In group 2, one subject had a total serum 25-OH vitamin D concentration less than 15 ng/mL. In this group, the distribution of 25-OH vitamin D2 and 25-OH vitamin D3 correlated well with serum vitamin D2 and D3 concentrations and whether patients received vitamin D2 or D3 supplementation. Serum 1,25(OH)2 vitamin D concentrations were normal in all but one subject in group 1, whereas in group 2 three subjects had reduced concentrations and two were elevated. In the three subjects in group 1 with rickets, concentrations of 25-OH vitamin D were reduced and 1,25(OH)2 vitamin D concentrations were normal.
Bone mineral content and radiograph findings are summarized in Table 3 . Only one subject in group 1 had a significantly reduced bone mineral content compared to age-matched controls; this subject also had rickets. Two additional subjects with rickets had normal age-adjusted bone mineral content. Despite normal age-matched bone mineral content, all but one subject was between 1 and 2 SD less than the mean, indicating that bone accretion is reduced in these subjects. In contrast, three of five subjects in group 2 had reduced bone mineral content and concurrently had reduced 1 ,25(OH)2 vitamin D concentrations. Two additional subjects had bone mineral content 1-2 SD less than the mean, suggesting impaired bone accretion. None had rickets; however, all had subjective radiographic evidence of osteopenia. ng/mL) in controls at 8 to 12 h. In one control, the peak was reached at 4 h. The area under the curve for the vitamin D2 tolerance test was 1900 f 183 ng x h/mL. Subjects in group 1 had either no rise in vitamin D2 above baseline or, in two subjects, rises to a peak of 1.5 and 2.2 ng/mL (Fig. 1) . The average peak rise above baseline was 0.9 + 0.6 ng/mL and the area under the curve for vitamin D2 absorption was 12.6 + 8.7 ng x h/mL. In group 2, the peak vitamin D2 concentration was 74.0 + 19.7 ng/mL (range 37-148 ng/mL). Similar to the controls, the peak concentration was attained at 8 h in two subjects, 12 h in two subjects, and 4 h in one subject. The area under the curve for the vitamin D2 tolerance test was 1704 k 437 ng x h/ mL for group 2 subjects. No significant differences between control and group 2 subjects for changes in vitamin D2 concentrations were noted at any time point. In addition, no significant difference in peak concentration or area under the absorption curve was noted between controls and subjects in group 2. In contrast, significant differences were noted in the peak change from baseline in serum vitamin D2 concentrations between both controls and group 2 subjects compared to subjects in group 1 at each time point (all < 0.00 1). The peak concentration above baseline in group 1 subjects was significantly less than subjects in group 2 ( p < 0.01) and controls ( p < 0.001). Finally, the area under the absorption curve for vitamin D2 in group 1 subjects was significantly reduced compared to group 2 ( p < 0.01) and controls ( p < 0.00 1).
25-OH vitamin D.
After a weight-adjusted dose of 25-OH vitamin D3 was given to controls, a rise above baseline of 53 to 240 ng/mL above baseline (mean 1 17.2 f 19.8 ng/mL) was found. The peak was seen between 3 and 8 h after administration of the test dose (Fig. 2) and the concentrations declined toward baseline at 24 h. In subjects in group 1, the peak rise of 25-OH vitamin D above baseline was 28.3 + 7.1 ng/mL with an area under the absorption curve of 335 k 99 ng x h/mL. For subjects in group 2, the peak rise of 25-OH vitamin D above baseline was 46.0 + 15.8 ng/mL and the area under the absorption curve was 5 16.8 +. 240.7 ng x h/mL. Neither the peak nor the area under the curve values differed between groups 1 and 2. In contrast, in the controls the peak (1 17.2 + 19.8 ng/mL) was significantly higher than group 1 ( p < 0.001) and group 2 (p < 0.05). In addition, in the controls the area under the absorption curve for 25-OH vitamin D (2020.7 + 47 1.5 ng x h/mL) was significantly higher than group 1 ( p < 0.00 1) and group 2 ( p < 0.05). disease is one in 10 000 to 15 000 live births (19) . At operation, about 10-1 5% of infants will have patent proximal hepatic ducts that do not communicate with the duodenum. The remainder have obliteration of the extrahepatic ducts to varying extent but generally involving the entire extrahepatic biliary tree. In infants with "correctable" forms of biliary atresia, a Roux-en-Y anastomosis of jejunum to hepatic duct may be performed with favorable results. In infants with "noncorrectable" forms, portal dissection is undertaken with placement of a Roux-en-Y anastomosis of jejunum to the undersurface of the liver capsule (2) . The magnitude of postoperative bile flow and resolution of jaundice are dependent on age at operation and ductal remnant size (20, 21) . Most patients have failure of establishment of postoperative bile flow and pursue a course of progressive liver failure eventuating in death, or transplantation in the first 2 y of life. A minority of patients has satisfactory postoperative bile flow, resolution of jaundice, and slow progression of portal cirrhosis with the development of portal hypertension with ascites and varices during the first decade of life.
Among patients with extrahepatic biliary atresia with poor immediate postoperative results, significant complications impair their quality of life. Rickets is a common complication and is found in 59% of surgically unrepaired infants with EHBA in a series by Kobayashi et al. (6) and 1211 8 infants with cholestatic liver disease by Roberts et al. (22) . The findings of reduced concentrations of serum 25-OH vitamin D and response to massive parenteral doses of vitamin D have led investigators to believe that severe intestinal malabsorption of vitamin D is responsible for production of rickets and bone disease in infants and children with hepatobiliary disease (23) (24) (25) (26) (27) .
In our study, we examined bone mineral content, baseline vitamin D metabolites, and absorption of vitamin D2 and 25-OH vitamin D j in infants and children with EHBA assigned to groups based on the success of the portoenterostomy. By definition, the groups differ substantially in age because patients with poor results rarely survive beyond age 2 y without orthotopic liver transplantation. However, there is no a priori reason to suggest that the age differences of the diseased patient groups or the controls should affect the results of the absorption studies. It is likely that the pathogenesis of bone disease in these patient groups may be multifactorial. In group 1, vitamin D deficiency plays a central role; however, additional factors also present in group 2 may affect bone mineral content. In the other group, factors such as reduced bone deposition, increased r~sorption or abnormal bone matrix may play more significant roles in the genesis of bone disease.
Radiographic evidence of rickets was present in three infants 30 HEUBI in group 1 with poor postoperative results. Only one had severely reduced bone mineral content (-3 SD). In the other four subjects, bone mineral content was reduced relative to control values (-1 to -2 SD). In contrast, three of five patients with "successful" repairs had significantly reduced bone mineral content and subjective evidence of osteopenia but no rickets. The apparent discrepancy between the finding of rickets without severe reduction in bone mineral content may relate to differences of bone site being examined. Rickets is usually diagnosed radiographically by changes observed at the distal end of the long bones such as the radius, whereas bone mineral content is measured as an average over the distal one-third site of the radius. Therefore, different mineralization processes are measured. Reduced bone mineral content in children more than 2 y of age (group 2) could reflect less rapid bone growth that is a reflection of prolonged abnormalities of bone metabolism. The specific etiology of the reduced bone density in older subjects theoretically might relate to reduced 1,25(OH)2 vitamin D concentrations, alterations in osteocalcin metabolism, exercise, chronic mineral malabsorption, or other nutritional factors. Preliminary results in subjects similar to those presented here suggest that calcium absorption is not impaired (28) . The most plausible hypothesis that may explain all of the biochemical derangements associated with reduced bone density is reduced exercise and activity in chronically ill children with liver disease. Strain imposed on bone by activity most likely diverts calcium and phosphorus from blood to bone. As a consequence, PTH secretion increases leading to increased 1,25(OH)2 vitamin D secretion (29) (30) (31) (32) . Although the effects of exercise have been studied in adults, no such studies have been performed in normal or diseased infants. This is also the subject of current investigation at our research unit. Measurable serum vitamin D2 or D3 was found in all subjects with successful portoenterostomies who were receiving vitamin D supplements and the distribution of 25-OH vitamin D metabolites reflected the supplemented component. No subjects with a poor result after portoenterostomy had measurable serum vitamin D2 or D j concentrations. In all but one subject with a poor result after portoenterostomy (group I), serum 25-OH vitamin D concentrations were below the lower limits of normal. Three of these five subjects also had rickets. Surprisingly, measurable 25-OH vitamin D2 concentrations were present despite the demonstration, in our study, that no measurable vitamin D2 appeared in the serum after a test dose of 1000 IU/kg. Measurable serum 25-OH vitamin D2 may result from release of 25-OH vitamin D2 stores (such as during fetal life) or minimal absorption of large doses of vitamin D2 administered on a daily basis to the subjects. Both possibilities are currently being examined. In previous studies in older cholestatic subjects, measurable 25-OH vitamin D2 was also found with large oral vitamin D2 supplements and no measurable serum vitamin D2 (7). Serum 1,25(OH)2 vitamin D concentrations were variable in both groups. In the patients with "failed" portoenterostomies, the concentrations were normal or minimally increased, a finding previously observed (28) . In contrast, in the older subjects with "successful" portoenterostomies, concentrations were either normal or low. Those with low concentrations had consistently reduced 1,25(OH)2 vitamin D concentrations. This finding is consistent with our previous work in older children with intrahepatic cholestasis and studies in adults (7, (34) (35) (36) . The reasons for the observed alterations in 1,25(OH)2 vitamin D concentrations are unknown. In the younger subjects, it would be anticipated that 1,25(OH)2 vitamin D concentrations would rise in the face of rickets or calcium deficiency as a compensatory mechanism to increase the efficiency of intestinal absorption and maximize calcium economy. In the older subjects, reduced concentrations cannot be explained. It is hypothesized that they may relate to 1) increased turnover and 2) impaired synthesis that may relate to chronic liver disease and decreased activity.
Vitamin D2 absorption was absent or minimal after an oral test dose in patients with "failed" portoenterostomies. This observation is consistent with findings in older patients with intrahepatic cholestasis (7). In contrast, in patients with "successful" portoenterostomies, and presumably adequate intraluminal bile salt concentrations, the rise of vitamin D2 above baseline after an oral test dose was similar to controls. Therefore, it appears that vitamin D2 absorption is unaffected when bile flow is reestablished in patients with extrahepatic biliary atresia. In addition, the observation of measurable or even high concentrations of serum vitamin D in these patients chronically supplemented with doses ranging from only 400 to 5000 IU/day reinforces the notion that vitamin D absorption is intact.
Absorption of 25-OH vitamin D appeared to be less impaired than vitamin D in patients with "failed" portoenterostornies. This finding is similar to observations in older children and adults (7, 37) . Animal studies have suggested that 1,25(OH)2 vitamin D and 25-OH vitamin D are better absorbed than vitamin D in the absence of bile salts (38, 39) . With increasing hydroxylation of the sterol ring of vitamin D, the molecule becomes more polar, more water soluble, and therefore better absorbed. Despite impaired uptake of 25-OH vitamin D, it would be anticipated that chronic administration would reliably allow maintenance of normal serum concentrations. In both children and adults with chronic cholestatic disease, chronic administration of 25-OH vitamin D has raised serum concentrations (27, 35) . Daum et al. (27) have previously treated three patients with extrahepatic biliary atresia with daily 50 pg 25-OH vitamin D with improvement in serum concentrations and improvement in rickets. Impaired 25-OH vitamin D absorption despite normal vitamin D absorption in patients with good bile flow was unexpected and a specific reason is not readily apparent. Studies are currently underway in our laboratories to investigate optimal dosages and the effect of chronic therapy with 25-OH vitamin D on bone density and serum concentrations in infants with chronic cholestasis.
Sunlight exposure might be a reliable means to stimulate endogenous synthesis of vitamin D in these patient populations.
Unfortunately, patients with portoenterostomy repair that does not reestablish bile flow tend to be debilitated and, in many cases, hospital bound. For this group, the use of 25-OH vitamin D appears to be a logical choice to prevent rickets and optimize bone metabolism before orthotopic liver transplantation. Unfortunately, because the pathogenesis of bone disease in all patients may relate, in part, to alterations in activity, it may be extremely difficult to normalize bone metabolism.
